CRISPR-Cas9 gene editing of inhibitory receptor signaling pathways improves CAR T cell activity against glioblastoma

被引：0
|
作者：
Sanber, Khaled [1 ]
Nawas, Zeid [1 ]
Salsman, Vita [1 ]
Gad, Ahmed [1 ]
Matthew, Pretty Rose [1 ]
Landi, Daniel [1 ]
Lee, Ciaran [2 ]
Sengal, Amel [1 ]
Chakraborty, Rikhia [1 ]
Joseph, Sujith [1 ]
Nabil, Ahmed [1 ]
Hegde, Meenakshi [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Rice Univ, Houston, TX USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2173
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Application of CRISPR-Cas9 gene editing for congenital heart disease
    Seok, Heeyoung
    Deng, Rui
    Cowan, Douglas B.
    Wang, Da-Zhi
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2021, 64 (06) : 269 - 279
  • [42] CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
    Fontana, Marianna
    Solomon, Scott D.
    Kachadourian, Jessica
    Walsh, Liron
    Rocha, Ricardo
    Lebwohl, David
    Smith, Derek
    Taubel, Jorg
    Gane, Edward J.
    Pilebro, Bjorn
    Adams, David
    Razvi, Yousuf
    Olbertz, Joy
    Haagensen, Alexandra
    Zhu, Peijuan
    Xu, Yuanxin
    Leung, Adia
    Sonderfan, Alison
    Gutstein, David E.
    Gillmore, Julian D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (23): : 2231 - 2241
  • [43] Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
    Papizan, James B.
    Porter, Shaina N.
    Sharma, Akshay
    Pruett-Miller, Shondra M.
    JOURNAL OF BIOMEDICAL RESEARCH, 2021, 35 (02): : 115 - 134
  • [44] Modelling the Cancer Phenotype in the Era of CRISPR-Cas9 Gene Editing
    Stewart, J.
    Banerjee, S.
    Pettitt, S. J.
    Lord, C. J.
    CLINICAL ONCOLOGY, 2020, 32 (02) : 69 - 74
  • [45] CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential
    Blenke, Erik Oude
    Evers, Martijn J. W.
    Mastrobattista, Enrico
    van der Oost, John
    JOURNAL OF CONTROLLED RELEASE, 2016, 244 : 139 - 148
  • [46] Recent Progress in Regulating CRISPR-Cas9 System for Gene Editing
    Gong Shaohua
    Li Na
    Tang Bo
    ACTA CHIMICA SINICA, 2020, 78 (07) : 634 - 641
  • [47] Is microfluidics the "assembly line" for CRISPR-Cas9 gene-editing?
    Ahmadi, Fatemeh
    Quach, Angela B. V.
    Shih, Steve C. C.
    BIOMICROFLUIDICS, 2020, 14 (06)
  • [48] Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
    James B.Papizan
    Shaina N.Porter
    Akshay Sharma
    Shondra M.Pruett-Miller
    The Journal of Biomedical Research, 2021, 35 (02) : 115 - 134
  • [49] The Potential Harms of Human Gene Editing Using CRISPR-Cas9
    Baylis, Francoise
    CLINICAL CHEMISTRY, 2018, 64 (03) : 489 - 491
  • [50] The transformative potential of AI-driven CRISPR-Cas9 genome editing to enhance CAR T-cell therapy
    1600, Elsevier Ltd (182):
12345